Cerus Corporation (CERS)
USD 1.16
(-6.45%)
USD 1.16
(-6.45%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -37.48 Million USD | 12.46% |
| 2022 | -42.82 Million USD | 21.24% |
| 2021 | -54.37 Million USD | 9.16% |
| 2020 | -59.85 Million USD | 15.98% |
| 2019 | -71.24 Million USD | -23.76% |
| 2018 | -57.56 Million USD | 4.99% |
| 2017 | -60.58 Million USD | 3.69% |
| 2016 | -62.9 Million USD | -12.6% |
| 2015 | -55.86 Million USD | -44.86% |
| 2014 | -38.56 Million USD | 11.01% |
| 2013 | -43.33 Million USD | -172.27% |
| 2012 | -15.91 Million USD | 6.27% |
| 2011 | -16.98 Million USD | -0.42% |
| 2010 | -16.91 Million USD | 29.93% |
| 2009 | -24.13 Million USD | 17.29% |
| 2008 | -29.18 Million USD | 35.59% |
| 2007 | -45.3 Million USD | -847.98% |
| 2006 | -4.77 Million USD | -136.58% |
| 2005 | 13.06 Million USD | 141.93% |
| 2004 | -31.15 Million USD | 46.53% |
| 2003 | -58.26 Million USD | -1.88% |
| 2002 | -57.19 Million USD | -15.85% |
| 2001 | -49.36 Million USD | -37.0% |
| 2000 | -36.03 Million USD | -59.44% |
| 1999 | -22.6 Million USD | 23.65% |
| 1998 | -29.6 Million USD | -101.36% |
| 1997 | -14.7 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -9.68 Million USD | -629.52% |
| 2024 Q3 | -2.93 Million USD | 49.19% |
| 2024 Q2 | -5.77 Million USD | 40.39% |
| 2023 Q4 | -1.32 Million USD | 81.73% |
| 2023 Q1 | -15.64 Million USD | -14.8% |
| 2023 FY | -37.48 Million USD | 12.46% |
| 2023 Q2 | -13.27 Million USD | 15.13% |
| 2023 Q3 | -7.26 Million USD | 45.26% |
| 2022 Q4 | -13.62 Million USD | -59.9% |
| 2022 FY | -42.82 Million USD | 21.24% |
| 2022 Q2 | -8.39 Million USD | 31.66% |
| 2022 Q3 | -8.52 Million USD | -1.5% |
| 2022 Q1 | -12.28 Million USD | -34.71% |
| 2021 Q2 | -15.36 Million USD | 12.01% |
| 2021 FY | -54.37 Million USD | 9.16% |
| 2021 Q4 | -9.11 Million USD | 26.68% |
| 2021 Q3 | -12.43 Million USD | 19.04% |
| 2021 Q1 | -17.45 Million USD | -21.39% |
| 2020 Q4 | -14.38 Million USD | -1.71% |
| 2020 Q2 | -14.87 Million USD | 9.69% |
| 2020 Q3 | -14.13 Million USD | 4.92% |
| 2020 FY | -59.85 Million USD | 15.98% |
| 2020 Q1 | -16.46 Million USD | 2.7% |
| 2019 Q4 | -16.92 Million USD | 5.81% |
| 2019 Q1 | -18.79 Million USD | -15.96% |
| 2019 FY | -71.24 Million USD | -23.76% |
| 2019 Q2 | -17.56 Million USD | 6.55% |
| 2019 Q3 | -17.96 Million USD | -2.31% |
| 2018 Q3 | -14.19 Million USD | -6.85% |
| 2018 Q2 | -13.28 Million USD | 4.34% |
| 2018 Q4 | -16.2 Million USD | -14.18% |
| 2018 Q1 | -13.88 Million USD | -20.89% |
| 2018 FY | -57.56 Million USD | 4.99% |
| 2017 Q2 | -17.08 Million USD | 8.15% |
| 2017 Q1 | -18.59 Million USD | -37.75% |
| 2017 Q3 | -13.41 Million USD | 21.45% |
| 2017 Q4 | -11.48 Million USD | 14.4% |
| 2017 FY | -60.58 Million USD | 3.69% |
| 2016 Q1 | -16.86 Million USD | -14.28% |
| 2016 Q2 | -18.16 Million USD | -7.73% |
| 2016 Q3 | -14.37 Million USD | 20.86% |
| 2016 Q4 | -13.5 Million USD | 6.09% |
| 2016 FY | -62.9 Million USD | -12.6% |
| 2015 FY | -55.86 Million USD | -44.86% |
| 2015 Q4 | -14.75 Million USD | 5.89% |
| 2015 Q3 | -15.68 Million USD | 1.83% |
| 2015 Q2 | -15.97 Million USD | -68.84% |
| 2015 Q1 | -9.46 Million USD | 52.68% |
| 2014 Q3 | -10.75 Million USD | -41.77% |
| 2014 Q1 | -225 Thousand USD | 96.16% |
| 2014 FY | -38.56 Million USD | 11.01% |
| 2014 Q4 | -19.99 Million USD | -85.83% |
| 2014 Q2 | -7.58 Million USD | -3272.89% |
| 2013 Q1 | -10.25 Million USD | -497.44% |
| 2013 Q4 | -5.86 Million USD | 71.42% |
| 2013 Q3 | -20.5 Million USD | -204.89% |
| 2013 Q2 | -6.72 Million USD | 34.41% |
| 2013 FY | -43.33 Million USD | -172.27% |
| 2012 FY | -15.91 Million USD | 6.27% |
| 2012 Q4 | -1.71 Million USD | 50.4% |
| 2012 Q3 | -3.46 Million USD | -81.44% |
| 2012 Q2 | -1.9 Million USD | 78.41% |
| 2012 Q1 | -8.83 Million USD | -10.47% |
| 2011 Q2 | -6.31 Million USD | -26.01% |
| 2011 Q3 | 2.26 Million USD | 135.8% |
| 2011 Q4 | -7.99 Million USD | -453.85% |
| 2011 FY | -16.98 Million USD | -0.42% |
| 2011 Q1 | -5.01 Million USD | -90.49% |
| 2010 FY | -16.91 Million USD | 29.93% |
| 2010 Q2 | -5.42 Million USD | -8.06% |
| 2010 Q1 | -5.02 Million USD | -2.72% |
| 2010 Q4 | -2.63 Million USD | 31.37% |
| 2010 Q3 | -3.83 Million USD | 29.39% |
| 2009 Q1 | -7.39 Million USD | -23.74% |
| 2009 Q3 | -5.63 Million USD | 9.26% |
| 2009 Q2 | -6.21 Million USD | 16.02% |
| 2009 Q4 | -4.88 Million USD | 13.27% |
| 2009 FY | -24.13 Million USD | 17.29% |
| 2008 Q3 | -8.81 Million USD | 3.02% |
| 2008 FY | -29.18 Million USD | 35.59% |
| 2008 Q4 | -5.97 Million USD | 32.21% |
| 2008 Q2 | -9.09 Million USD | -71.83% |
| 2008 Q1 | -5.29 Million USD | 53.7% |
| 2007 Q3 | -9.15 Million USD | 48.92% |
| 2007 Q1 | -6.8 Million USD | -326.18% |
| 2007 Q4 | -11.43 Million USD | -24.9% |
| 2007 FY | -45.3 Million USD | -847.98% |
| 2007 Q2 | -17.91 Million USD | -163.15% |
| 2006 FY | -4.77 Million USD | -136.58% |
| 2006 Q3 | -1.78 Million USD | 64.77% |
| 2006 Q4 | 3.01 Million USD | 268.44% |
| 2006 Q1 | -930 Thousand USD | 76.12% |
| 2006 Q2 | -5.07 Million USD | -445.38% |
| 2005 Q1 | 21.38 Million USD | 499.57% |
| 2005 Q2 | -2.76 Million USD | -112.91% |
| 2005 Q3 | -1.66 Million USD | 39.66% |
| 2005 FY | 13.06 Million USD | 141.93% |
| 2005 Q4 | -3.89 Million USD | -133.73% |
| 2004 Q1 | -9.19 Million USD | 9.22% |
| 2004 Q2 | -11.54 Million USD | -25.59% |
| 2004 Q3 | -5.06 Million USD | 56.18% |
| 2004 Q4 | -5.35 Million USD | -5.77% |
| 2004 FY | -31.15 Million USD | 46.53% |
| 2003 Q3 | -14.2 Million USD | 15.29% |
| 2003 Q2 | -16.77 Million USD | 2.26% |
| 2003 Q4 | -10.12 Million USD | 28.72% |
| 2003 Q1 | -17.15 Million USD | -8.81% |
| 2003 FY | -58.26 Million USD | -1.88% |
| 2002 Q3 | -16.59 Million USD | -47.03% |
| 2002 Q1 | -13.54 Million USD | -0.34% |
| 2002 FY | -57.19 Million USD | -15.85% |
| 2002 Q2 | -11.28 Million USD | 16.7% |
| 2002 Q4 | -15.77 Million USD | 4.95% |
| 2001 Q2 | -11.97 Million USD | -7.25% |
| 2001 FY | -49.36 Million USD | -37.0% |
| 2001 Q4 | -13.5 Million USD | -6.09% |
| 2001 Q3 | -12.72 Million USD | -6.27% |
| 2001 Q1 | -11.16 Million USD | -2.62% |
| 2000 FY | -36.03 Million USD | -59.44% |
| 2000 Q1 | -7.51 Million USD | -5.89% |
| 2000 Q4 | -10.88 Million USD | -18.82% |
| 2000 Q3 | -9.15 Million USD | -8.01% |
| 2000 Q2 | -8.47 Million USD | -12.77% |
| 1999 Q3 | -5.5 Million USD | 0.0% |
| 1999 Q1 | -4.5 Million USD | 28.57% |
| 1999 FY | -22.6 Million USD | 23.65% |
| 1999 Q4 | -7.1 Million USD | -29.09% |
| 1999 Q2 | -5.5 Million USD | -22.22% |
| 1998 Q2 | -13.7 Million USD | -280.56% |
| 1998 Q1 | -3.6 Million USD | 20.0% |
| 1998 FY | -29.6 Million USD | -101.36% |
| 1998 Q3 | -6.1 Million USD | 55.47% |
| 1998 Q4 | -6.3 Million USD | -3.28% |
| 1997 Q3 | -1.9 Million USD | 54.76% |
| 1997 Q2 | -4.2 Million USD | -2.44% |
| 1997 FY | -14.7 Million USD | 0.0% |
| 1997 Q1 | -4.1 Million USD | 0.0% |
| 1997 Q4 | -4.5 Million USD | -136.84% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 39.159% |
| IceCure Medical Ltd | -14.65 Million USD | -155.863% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -216.11% |
| Acutus Medical, Inc. | -81.66 Million USD | 54.093% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 5955.863% |
| Bioventus Inc. | -156.23 Million USD | 76.004% |
| BrainsWay Ltd. | -4.19 Million USD | -793.233% |
| Venus Concept Inc. | -37.25 Million USD | -0.642% |
| Envoy Medical, Inc. | -29.9 Million USD | -25.348% |
| CVRx, Inc. | -41.19 Million USD | 9.005% |
| electroCore, Inc. | -18.83 Million USD | -99.05% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -323.605% |
| Inogen, Inc. | -102.44 Million USD | 63.407% |
| OrthoPediatrics Corp. | -20.97 Million USD | -78.74% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 28.817% |
| Spectral AI, Inc. | -20.85 Million USD | -79.769% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -172.742% |
| MaxCyte, Inc. | -37.92 Million USD | 1.144% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 38.316% |
| Nexalin Technology, Inc. | -4.64 Million USD | -706.439% |
| Orthofix Medical Inc. | -151.39 Million USD | 75.238% |
| PAVmed Inc | -64.17 Million USD | 41.583% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 28.547% |
| RxSight, Inc. | -48.6 Million USD | 22.875% |
| Sight Sciences, Inc. | -55.54 Million USD | 32.509% |
| SI-BONE, Inc. | -43.33 Million USD | 13.492% |
| TELA Bio, Inc. | -46.66 Million USD | 19.662% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 24.306% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -175.999% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 36.5% |
| LivaNova PLC | 17.54 Million USD | 313.661% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -242.2% |
| Talis Biomedical Corporation | -62 Million USD | 39.541% |
| 908 Devices Inc. | -36.39 Million USD | -2.995% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 79.914% |
| Nemaura Medical Inc. | -14.14 Million USD | -165.057% |
| NeuroPace, Inc. | -32.95 Million USD | -13.755% |
| LENSAR, Inc. | -14.38 Million USD | -160.648% |
| Apyx Medical Corporation | -18.71 Million USD | -100.337% |
| Cutera, Inc. | -162.83 Million USD | 76.977% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -246.159% |
| BioSig Technologies, Inc. | -29.04 Million USD | -29.09% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 54.651% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | -69.718% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 155.342% |
| Axonics, Inc. | -6.08 Million USD | -515.785% |
| Outset Medical, Inc. | -172.79 Million USD | 78.305% |
| IRIDEX Corporation | -9.57 Million USD | -291.735% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 64.599% |
| IRadimed Corporation | 17.19 Million USD | 318.051% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -354.743% |
| INVO Bioscience, Inc. | -8.03 Million USD | -366.594% |
| Telesis Bio, Inc. | -47.72 Million USD | 21.446% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 465.996% |
| Varex Imaging Corporation | -47.7 Million USD | 21.407% |
| Quipt Home Medical Corp. | -2.78 Million USD | -1246.588% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -232.173% |
| Pulmonx Corporation | -60.84 Million USD | 38.384% |
| Dynatronics Corporation | -2.69 Million USD | -1289.655% |
| Modular Medical, Inc. | -17.47 Million USD | -114.591% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -229.226% |
| Semler Scientific, Inc. | 20.58 Million USD | 282.136% |
| InMode Ltd. | 197.91 Million USD | 118.942% |
| Bruker Corporation | 427.2 Million USD | 108.776% |
| Cytosorbents Corporation | -28.5 Million USD | -31.506% |
| DexCom, Inc. | 541.5 Million USD | 106.923% |
| Align Technology, Inc. | 445.05 Million USD | 108.423% |
| Viveve Medical, Inc. | -22.02 Million USD | -70.196% |
| ZimVie Inc. | -393.28 Million USD | 90.468% |
| Movano Inc. | -29.28 Million USD | -28.023% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -208.602% |
| Nexalin Technology, Inc. | -4.64 Million USD | -706.439% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 5955.863% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 83.159% |
| Profound Medical Corp. | -28.56 Million USD | -31.223% |
| Insulet Corporation | 206.3 Million USD | 118.172% |
| enVVeno Medical Corporation | -23.51 Million USD | -59.419% |
| Surmodics, Inc. | -11.54 Million USD | -224.805% |
| iCAD, Inc. | -4.84 Million USD | -673.447% |
| Nuwellis, Inc. | -20.2 Million USD | -85.506% |
| Biotricity, Inc. | -14.09 Million USD | -165.987% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 69.621% |
| Aethlon Medical, Inc. | -12.2 Million USD | -207.081% |
| InspireMD, Inc. | -19.91 Million USD | -88.236% |
| PAVmed Inc. | -64.17 Million USD | 41.583% |
| BIOLASE, Inc. | -20.63 Million USD | -81.703% |
| Beyond Air, Inc. | -60.24 Million USD | 37.769% |
| FONAR Corporation | 10.56 Million USD | 454.761% |
| AxoGen, Inc. | -21.71 Million USD | -72.633% |
| Vivani Medical, Inc. | -25.65 Million USD | -46.145% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 231.471% |
| Inari Medical, Inc. | -1.63 Million USD | -2191.504% |
| UFP Technologies, Inc. | 44.92 Million USD | 183.45% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -630.448% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -467.567% |
| Tenon Medical, Inc. | -15.58 Million USD | -140.607% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -143.025% |
| Co-Diagnostics, Inc. | -35.33 Million USD | -6.102% |
| AdaptHealth Corp. | -678.89 Million USD | 94.478% |
| Sintx Technologies, Inc. | -8.25 Million USD | -353.917% |
| NanoVibronix, Inc. | -3.71 Million USD | -910.213% |
| Quanterix Corporation | -32.33 Million USD | -15.943% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -232.173% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 7829.691% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 87.778% |
| TransMedics Group, Inc. | -25.02 Million USD | -49.788% |
| ReWalk Robotics Ltd. | -22.13 Million USD | -69.381% |
| NeuroMetrix, Inc. | -6.52 Million USD | -474.149% |
| Hyperfine, Inc. | -44.23 Million USD | 15.256% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 52.245% |
| Biomerica, Inc. | -5.97 Million USD | -527.116% |
| Bone Biologics Corporation | -8.94 Million USD | -318.931% |
| AVITA Medical, Inc. | -39.16 Million USD | 4.287% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -276.627% |
| Silk Road Medical, Inc | -55.74 Million USD | 32.747% |